CN Patent

CN113811305A — 带电的离子通道阻滞剂及其使用方法

Assigned to Nosian Medical · Expires 2021-12-17 · 4y expired

What this patent protects

本发明提供了式(I)化合物或其药学上可接受的盐：本发明的化合物、组合物、方法或者试剂盒可以有效用于治疗疼痛、咳嗽、瘙痒以及神经源性炎症。

USPTO Abstract

本发明提供了式(I)化合物或其药学上可接受的盐：本发明的化合物、组合物、方法或者试剂盒可以有效用于治疗疼痛、咳嗽、瘙痒以及神经源性炎症。

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN113811305A
Jurisdiction: CN
Classification: —
Expires: 2021-12-17
Drug substance claim: No
Drug product claim: No
Assignee: Nosian Medical
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.